As an example, quite a few pharmaceutical companies are buying acquiring psychedelics as prescription medicines.82 Examples of this expanding desire include the breakthrough therapy designation granted through the US Foodstuff and Drug Administration for the trials of psilocybin for significant depression funded via the Usona Institute and for cure-resistant despair https://www.evernote.com/shard/s719/sh/330863cc-f66e-28c9-1f41-da0804b81796/RMpoTb0riW3RmWT16RjoS367Hafssl_5BT2tyYmOPBlf01wp-Yuv0jPVlw